Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886452 · ClinicalTrials.gov registry record
Success of Dailies Total1 for Astigmatism Contact Lenses in Patients That Have Previously Failed With Toric Contact Lenses
A clinical trial, sponsored by Mann Eye Institute.
- Completed
- Registry status
- 65
- Enrollment target
NCT05886452: Completed study, sponsored by Mann Eye Institute.
NCT05886452 is a clinical trial that has completed, run by Mann Eye Institute. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05886452 has completed, sponsored by Mann Eye Institute.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The objective is to determine the percentages of past toric CL wearers (who dropped out of contact lens wear due to dissatisfaction with comfort or vision) who are satisfied with the comfort and vision of DT1fA contact lenses.
Primary Outcome
A questionnaire will be administered. Subjects are asked to rate their satisfaction with comfort and vision on a scale of 0 to 100, with higher ratings indicating higher satisfaction with comfort and vision.
Interventions
- DEVICE DT1fA contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2024-04-01 |
What the finished NCT05886452 record still lists
NCT05886452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which DT1fA contact lenses is the first listed.
NCT05886452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05886452 about?
NCT05886452 is a clinical study titled "Success of Dailies Total1 for Astigmatism Contact Lenses in Patients That Have Previously Failed With Toric Contact Lenses". The objective is to determine the percentages of past toric CL wearers (who dropped out of contact lens wear due to dissatisfaction with comfort or vision) who are satisfied with the comfort and vision of DT1fA contact lenses.
What is the current status of trial NCT05886452?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2023-08-01. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT05886452?
The interventions under investigation include: DT1fA contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05886452?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI